A new mobility company, Cerence, is making its public-market debut Wednesday, and its first CEO, Sanjay Dhawan, says he’s been meeting with more than 50 investors in recent weeks to talk up its prospects.
Cerence is a spinout from pioneering... Read more »
[Updated 5:58 p.m. PT. See below.] Organovo, a company developing technology to 3D print human tissue, announced two months ago that its dwindling cash is leading it to explore options that include merging with another firm. The San... Read more »
Austin — There are so many great things about working from home. Spending all day with your pets is up there, but not having to commute is probably the best.
It’s particularly nice to avoid commuting by car in a city... Read more »
Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades.
Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers... Read more »
Michael Ehlers, Biogen’s executive vice president of research and development, is leaving for a job in venture capital and an opportunity to lead a gene therapy startup.
Ehlers has been appointed chief scientific officer and venture partner of New York-based Apple... Read more »
The European Society for Medical Oncology meeting has wrapped up in Barcelona, the last major clinical cancer conference until December’s annual ASH meeting for blood diseases. We’ve highlighted a few top stories for you.
Amid all the fuss over cell, gene,... Read more »
In the past three years, Dova Pharmaceuticals has completed a company launch, gone public, and won its first drug approval. Now the biotech is in line to be acquired by Swedish Orphan Biovitrum (Sobi).
According to deal terms announced Monday, Dova... Read more »
A number of gene-editing companies have joined the public markets in recent years. Beam Therapeutics, which is developing a CRISPR-based technology intended to offer even more precise genomic edits, aims to become the latest one.
Cambridge, MA-based Beam filed its IPO... Read more »